CLINICAL_TRIALS
trial_result
· 2023-10-10
Clinical Trial Update: A Study of Zanubrutinib in Patients With ITP [Phase 2]
Summary
Phase 2 trial update of Zanubrutinib in immune thrombocytopenia (ITP) completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking University People's Hospital | Conditions: Immune Thrombocytopenia, Bruton Tyrosine Kinase | Phase 2 | Status: COMPLETED